Portal de Periódicos da CAPES

Redefining treatment options in chronic hand eczema (CHE)

2010; Wiley; Volume: 24; Issue: s3 Linguagem: Inglês

10.1111/j.1468-3083.2010.03615.x

1468-3083

Robert Bissonnette, Thomas L. Diepgen, Peter Elsner, John English, Robin Graham‐Brown, Bernhard Homey, Thomas A. Luger, Charles Lynde, J. Maares, Howard I. Maibach,

Dermatology and Skin Diseases

Journal of the European Academy of Dermatology and VenereologyVolume 24, Issue s3 p. 1-20 Redefining treatment options in chronic hand eczema (CHE) Robert Bissonnette, Robert Bissonnette Innovaderm Research, Montreal, QC, CanadaSearch for more papers by this authorThomas L. Diepgen, Thomas L. Diepgen Department of Social Medicine, Occupational and Environmental Dermatology, University Hospital of Heidelberg, Heidelberg, GermanySearch for more papers by this authorPeter Elsner, Peter Elsner Friedrich Schiller University, Jena, GermanySearch for more papers by this authorJohn English, John English University Hospitals of Leicester, Leicester, UKSearch for more papers by this authorRobin Graham-Brown, Robin Graham-Brown University Hospitals of Leicester, Leicester, UKSearch for more papers by this authorBernhard Homey, Bernhard Homey Heinrich-Heine-University, Düsseldorf, GermanySearch for more papers by this authorThomas Luger, Corresponding Author Thomas Luger University Clinics Münster, Münster, Germany *T Luger. E-mail:[email protected]Search for more papers by this authorCharles Lynde, Charles Lynde Lynderm Research, Markham, ON, CanadaSearch for more papers by this authorJürgen Maares, Jürgen Maares Basilea Pharmaceutica International Ltd, Basel, SwitzerlandSearch for more papers by this authorHoward I. Maibach, Howard I. Maibach University of California, San Francisco, CA, USASearch for more papers by this author Robert Bissonnette, Robert Bissonnette Innovaderm Research, Montreal, QC, CanadaSearch for more papers by this authorThomas L. Diepgen, Thomas L. Diepgen Department of Social Medicine, Occupational and Environmental Dermatology, University Hospital of Heidelberg, Heidelberg, GermanySearch for more papers by this authorPeter Elsner, Peter Elsner Friedrich Schiller University, Jena, GermanySearch for more papers by this authorJohn English, John English University Hospitals of Leicester, Leicester, UKSearch for more papers by this authorRobin Graham-Brown, Robin Graham-Brown University Hospitals of Leicester, Leicester, UKSearch for more papers by this authorBernhard Homey, Bernhard Homey Heinrich-Heine-University, Düsseldorf, GermanySearch for more papers by this authorThomas Luger, Corresponding Author Thomas Luger University Clinics Münster, Münster, Germany *T Luger. E-mail:[email protected]Search for more papers by this authorCharles Lynde, Charles Lynde Lynderm Research, Markham, ON, CanadaSearch for more papers by this authorJürgen Maares, Jürgen Maares Basilea Pharmaceutica International Ltd, Basel, SwitzerlandSearch for more papers by this authorHoward I. Maibach, Howard I. Maibach University of California, San Francisco, CA, USASearch for more papers by this author First published: 26 March 2010 https://doi.org/10.1111/j.1468-3083.2010.03615.xCitations: 41Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat References 1 Meding B, Wrangsjo K, Jarvholm B. Fifteen-year follow-up of hand eczema: persistence and consequences. Br J Dermatol 2005; 152: 975–980. 10.1111/j.1365-2133.2005.06494.x CASPubMedWeb of Science®Google Scholar 2 Diepgen TL, Agner T, Aberer W et al. Management of chronic hand eczema. Contact Dermatitis 2007; 57: 203–210. 10.1111/j.1600-0536.2007.01179.x PubMedWeb of Science®Google Scholar 3 McDonald C, Wheatley M. Epidemiology of Work Related Diseases. 2nd edn. BMJ Books, London, 2000. 10.1002/9780470695005 Google Scholar 4 Meding B, Jarvholm B. Hand eczema in Swedish adults – changes in prevalence between 1983 and 1996. J Invest Dermatol 2002; 118: 719–723. 10.1046/j.1523-1747.2002.01718.x CASPubMedWeb of Science®Google Scholar 5 Menne T, Maibach HI. Hand Eczema. 2nd edn. CRC Press, Boca Raton, Florida London, 2000. Google Scholar 6 Hogan DJ, Dannaker CJ, Maibach HI. The prognosis of contact dermatitis. J Am Acad Dermatol 1990; 23: 300–307. 10.1016/0190-9622(90)70213-2 PubMedWeb of Science®Google Scholar 7 Landow K. Hand dermatitis. The perennial scourge. Postgrad Med 1998; 103: 141–152. 10.3810/pgm.1998.01.276 CASPubMedWeb of Science®Google Scholar 8 Meding B, Wrangsjo K, Jarvholm B. Fifteen-year follow-up of hand eczema: predictive factors. J Invest Dermatol 2005; 124: 893–897. 10.1111/j.0022-202X.2005.23723.x CASPubMedWeb of Science®Google Scholar 9 Rook AT, Burns TF. Rook's Textbook of Dermatology. 7th edn. Edited by B Tony et al. Blackwell Publishing, Oxford, 2004. Google Scholar 10 Coenraads PJ, Van Der Walle H, Thestrup-Pedersen K et al. Construction and validation of a photographic guide for assessing severity of chronic hand dermatitis. Br J Dermatol 2005; 152: 296–301. 10.1111/j.1365-2133.2004.06270.x CASPubMedWeb of Science®Google Scholar 11 Held E, Skoet R, Johansen JD, Agner T. The hand eczema severity index (HECSI): a scoring system for clinical assessment of hand eczema. A study of inter- and intraobserver reliability. Br J Dermatol 2005; 152: 302–307. 10.1111/j.1365-2133.2004.06305.x CASPubMedWeb of Science®Google Scholar 12 Ruzicka T, Larsen FG, Galewicz D et al. Oral alitretinoin (9-cis-retinoic acid) therapy for chronic hand dermatitis in patients refractory to standard therapy: results of a randomized, double-blind, placebo-controlled, multicenter trial. Arch Dermatol 2004; 140: 1453–1459. 10.1001/archderm.140.12.1453 CASPubMedWeb of Science®Google Scholar 13 Spruit D, Malten KE. Epidermal water-barrier formation after stripping of normal skin. J Invest Dermatol 1965; 45: 6–14. 10.1038/jid.1965.83 CASPubMedWeb of Science®Google Scholar 14 Pototskii II, Diachenko EI. Gas exchange through the skin and glycolytic processes in it in eczema. Vestn Dermatol Venerol 1967 41: 32–36. CASPubMedGoogle Scholar 15 Frame GW, Strauss WG, Maibach HI. Carbon dioxide emission of the human arm and hand. J Invest Dermatol 1972; 59: 155–159. 10.1111/1523-1747.ep12625939 CASPubMedWeb of Science®Google Scholar 16 Anjo DM, Maibach H. Transepidermal chloride flux through hydrated skin: combination chloride electrode. Br J Dermatol 1981; 105: 39–44. 10.1111/j.1365-2133.1981.tb00880.x CASPubMedWeb of Science®Google Scholar 17 Wilson D, Severinghaus J, Maibach H. Newborn infant and adult transcutaneous PO2 resistance: a comparison. Arch Derm Res 1981; 271: 119–125. 10.1007/BF00412537 Web of Science®Google Scholar 18 Lo JS, Oriba HA, Maibach HI, Bailin PL. Transepidermal potassium ion, chloride ion, and water flux across delipidized and cellophane tape-stripped skin. Dermatologica 1990; 180: 66–68. 10.1159/000247992 CASPubMedWeb of Science®Google Scholar 19 Dreher F, Arens A, Hostynek JJ, Mudumba S, Ademola J, Maibach HI. Colorimetric method for quantifying human Stratum corneum removed by adhesive-tape stripping. Acta Derm Venereol 1998; 78: 186–189. 10.1080/000155598441495 CASPubMedWeb of Science®Google Scholar 20 Morhenn VB, Chang EY, Rheins LA. A noninvasive method for quantifying and distinguishing inflammatory skin reactions. J Am Acad Dermatol 1999; 41: 687–692. 10.1016/S0190-9622(99)70002-2 CASPubMedWeb of Science®Google Scholar 21 Zhai H, Maibach HI. Occlusion vs. skin barrier function. Skin Res Technol 2002; 8: 1–6. 10.1046/j.0909-752x.2001.10311.x PubMedWeb of Science®Google Scholar 22 Marzulli FN, Zhai H, Maibach HI, Wilhelm K-P. Marzulli and Maibach's Dermatotoxicology. 7th edn. London, Boca Raton, Florida, CRC, 2008. Google Scholar 23 Gorzelanny C, Goerge T, Schnaeker EM, Thomas K, Luger TA, Schneider SW. Atomic force microscopy as an innovative tool for nanoanalysis of native stratum corneum. Exp Dermatol 2006; 15: 387–391. 10.1111/j.0906-6705.2006.00424.x CASPubMedWeb of Science®Google Scholar 24 Huck V, Gorzelanny C, Thomas K, Luger TA, König K, Schneider SW. 5D-intravital tomography as a novel tool for non-invasive in-vivo analysis of human skin. Exp Dermatol 2009; 18: 1089. Web of Science®Google Scholar 25 Karan A, Alikhan A, Maibach HI. Toxicologic implications of cutaneous barriers: a molecular, cellular, and anatomical overview. J Appl Toxicol 2009; 29: 551–559. 10.1002/jat.1461 CASPubMedWeb of Science®Google Scholar 26 Meding B, Swanbeck G. Consequences of having hand eczema. Contact Dermatitis 1990; 23: 6–14. 10.1111/j.1600-0536.1990.tb00076.x CASPubMedWeb of Science®Google Scholar 27 Cvetkovski RS, Rothman KJ, Olsen J et al. Relation between diagnoses on severity, sick leave and loss of job among patients with occupational hand eczema. Br J Dermatol 2005; 152: 93–98. 10.1111/j.1365-2133.2005.06415.x CASPubMedWeb of Science®Google Scholar 28 Van Coevorden AM. Hand eczema: clinical efficacy of interventions, and burden of disease. Appendix 1: Comparison of economic outcomes of oral PUVA with a portable tanning unit at home vs. hospital administered bath PUVA in patients with CHE. 2005. Google Scholar 29 Diepgen T, Hieke K. Cost of illness of work-related chronic hand eczema in Germany. Value in Health 2008; 11: A290–A291. 10.1016/S1098-3015(10)70916-5 Web of Science®Google Scholar 30 Meding B. Epidemiology of hand eczema in an industrial city. Acta Derm Venereol Suppl (Stockh) 1990; 153: 1–43. CASPubMedGoogle Scholar 31 Marks R. Practical Problems in Dermatology. 2nd edn. Martin Dunitz, London, 1996. Google Scholar 32 Belsito DV, Fowler JF Jr, Marks JG Jr et al. Pimecrolimus cream 1%: a potential new treatment for chronic hand dermatitis. Cutis 2004; 73: 31–38. PubMedWeb of Science®Google Scholar 33 Halpern SM, Anstey AV, Dawe RS et al. Guidelines for topical PUVA: a report of a workshop of the British photodermatology group. Br J Dermatol 2000; 142: 22–31. 10.1046/j.1365-2133.2000.03237.x CASPubMedWeb of Science®Google Scholar 34 Thestrup-Pedersen K, Andersen KE, Menne T, Veien NK. Treatment of hyperkeratotic dermatitis of the palms (eczema keratoticum) with oral acitretin. A single-blind placebo-controlled study. Acta Derm Venereol 2001; 81: 353–355. 10.1080/000155501317140089 CASPubMedWeb of Science®Google Scholar 35 Granlund H, Erkko P, Eriksson E, Reitamo S. Comparison of cyclosporine and topical betamethasone-17,21-dipropionate in the treatment of severe chronic hand eczema. Acta Derm Venereol 1996; 76: 371–376. 10.2340/0001555576371376 CASPubMedWeb of Science®Google Scholar 36 Berth-Jones J, Takwale A, Tan E et al. Azathioprine in severe adult atopic dermatitis: a double-blind, placebo-controlled, crossover trial. Br J Dermatol 2002; 147: 324–330. 10.1046/j.1365-2133.2002.04989.x CASPubMedWeb of Science®Google Scholar 37 Van Coevorden AM, Coenraads PJ, Svensson A et al. Overview of studies of treatments for hand eczema-the EDEN hand eczema survey. Br J Dermatol 2004; 151: 446–451. 10.1111/j.1365-2133.2004.06040.x CASPubMedWeb of Science®Google Scholar 38 Nagpal S, Chandraratna RA. Recent developments in receptor-selective retinoids. Curr Pharm Des 2000; 6: 919–931. 10.2174/1381612003400146 CASPubMedWeb of Science®Google Scholar 39 Freedberg IM. Fitzpatrick's Dermatology in General Medicine. 5th edn. McGraw-Hill, Health Professions Division, New York, London, 1999. Google Scholar 40 Geiger JM, Hommel L, Harms M, Saurat JH. Oral 13-cis retinoic acid is superior to 9-cis retinoic acid in sebosuppression in human beings. J Am Acad Dermatol 1996; 34: 513–515. 10.1016/S0190-9622(96)90462-4 CASPubMedWeb of Science®Google Scholar 41 Ott F, Bollag W, Geiger JM. Oral 9-cis-retinoic acid versus 13-cis-retinoic acid in acne therapy. Dermatology 1996; 193: 124–126. 10.1159/000246226 CASPubMedWeb of Science®Google Scholar 42 Kurie JM, Lee JS, Griffin T et al. Phase I trial of 9-cis retinoic acid in adults with solid tumors. Clin Cancer Res 1996; 2: 287–293. CASPubMedWeb of Science®Google Scholar 43 Weber C, Dumont E. Pharmacokinetics and pharmacodynamics of 9-cis-retinoic acid in healthy men. J Clin Pharmacol 1997; 37: 566–574. 10.1002/j.1552-4604.1997.tb04338.x CASPubMedWeb of Science®Google Scholar 44 Coenraads PJ, Van Der Wetering J, Roos B, Schmitt-Hoffmann AH. Pharmacokinetics, efficacy and safety of alitretinoin (9-cis retinoic acid) in moderate or severe refractory chronic hand eczema. Poster FP1620 presented at EADV 2008 in Paris. Google Scholar 45 Schmitt-Hoffmann AH, Roos B, Baumgaertner E et al. Alitretinoin (9-cis retinoic acid): pharmacokinetic interactions between alitretinoin, ketoconazole, simvastatin and cyclosporine A. Poster 286 presented at EADV 2007 in Vienna. Google Scholar 46 Schmitt-Hoffmann A, Roos B, Kovacs P et al. Influence of food on the pharmacokinetics of oral alitretinoin (9-cis retinoic acid; BAL4079). Poster FP1611 presented at EADV 2008 in Paris. Google Scholar 47 Meller S, Lauerma AI, Kopp FM et al. Chemokine responses distinguish chemical-induced allergic from irritant skin inflammation: memory T cells make the difference. J Allergy Clin Immunol 2007; 119: 1470–1480. 10.1016/j.jaci.2006.12.654 CASPubMedWeb of Science®Google Scholar 48 Ruzicka T, Lynde CW, Jemec GB et al. Efficacy and safety of oral alitretinoin (9-cis retinoic acid) in patients with severe chronic hand eczema refractory to topical corticosteroids: results of a randomized, double-blind, placebo-controlled, multicentre trial. Br J Dermatol 2008; 158: 808–817. 10.1111/j.1365-2133.2008.08487.x CASPubMedWeb of Science®Google Scholar 49 Bissonnette R, Worm M, Gerlach B et al. Successful retreatment with alitretinoin in patients with relapsed chronic hand eczema. Br J Dermatol 2010; 162: 420–426. 10.1111/j.1365-2133.2009.09572.x CASPubMedWeb of Science®Google Scholar 50 Diepgen T, Maleszka R, Bissonnette R et al. An open label study of the safety and efficacy of alitretinoin in severe refractory chronic hand eczema. Poster 281 presented at EADV 2007 in Vienna. Google Scholar 51 Diepgen TL, Elsner P, Schliemann S et al. Guideline on the management of hand eczema ICD-10 Code: L20. L23. L24. L25. L30. J Dtsch Dermatol Ges 2009; 7(Suppl. 3): S1–S16. 10.1111/j.1610-0379.2009.07061.x PubMedWeb of Science®Google Scholar Citing Literature Volume24, Issues3Special Issue:Redefining Treatment Options in Chronic Hand EczemaMay 2010Pages 1-20 ReferencesRelatedInformation